Prospective real-world experience with cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study

Gennigens, Christine; De Ruyter, Vincent; De Sutter, David; Rottey, Sylvie

Paper published in a journal (Scientific congresses and symposiums)

Gennigens, Christine; De Ruyter, Vincent; De Sutter, David et al.

2024 • In European Urology Open Science

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/324834

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S2666168324013065-main.pdf

Publisher postprint (71.94 kB)

Creative Commons License - Attribution, Non-Commercial, No Derivative

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Oncology

Author, co-author :

Gennigens, Christine ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale

De Ruyter, Vincent; Ipsen, Medical Department, Merelbeke, Belgium

De Sutter, David; Ipsen, Medical Department, Merelbeke, Belgium

Rottey, Sylvie; UZ Gent, Dept. of Medical Oncology, Ghent, Belgium > Dept. of Medical Oncology, Ghent, Belgium

Language :

English

Title :

Prospective real-world experience with cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study

Publication date :

2024

Event name :

16th European Multidisciplinary Congress on Urological Cancers (EMUC24)

Event place :

Lisbon, Portugal

Event date :

7-10 November 2024

Audience :

International

Journal title :

European Urology Open Science

ISSN :

2666-1683

Publisher :

Elsevier, Amsterdam, Netherlands

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 02 December 2024

Statistics

Number of views

6 (1 by ULiège)

Number of downloads

3 (0 by ULiège)

More statistics